Search research articles
Contact Us
Filters
Showing results (191-200 of 252) with videos related to
Page
of 26
Sort By:
Journal of the American College of Cardiology
|
January 5, 2008
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials
Stuart J Pocock, Alexandra J Lansky, Roxana Mehran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
July 8, 2021
Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement
Toshiaki Isogai, Anas M Saad, Keerat Rai Ahuja, et al.
JACC. Cardiovascular Interventions
|
April 23, 2011
Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators
Stephen G Ellis, Mehdi H Shishehbor, Samir R Kapadia, et al.
Coronary Artery Disease
|
June 10, 2014
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies
Nobuaki Kobayashi, Akiko Maehara, Dominic Allocco, et al.
Human Genetics
|
November 4, 2009
The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies
Sonny Dandona, Li Chen, Meng Fan, et al.
The American Journal of Cardiology
|
January 15, 2022
A Validated Model to Identify Patients With Low Likelihood of High-Risk Coronary Artery Disease Anatomy
Amr F Barakat, Ram Amuthan, Essa Hariri, et al.
JACC. Cardiovascular Interventions
|
February 5, 2010
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials
Hiroshi Doi, Akiko Maehara, Gary S Mintz, et al.
Journal of the American College of Cardiology
|
October 17, 2009
Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards
David E Kandzari, Antonio Colombo, Seung-Jung Park, et al.
Journal of the American College of Cardiology
|
June 6, 2006
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials
Jeffrey W Moses, Gregg W Stone, Eugenia Nikolsky, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 13, 2007
Five common gene variants identify elevated genetic risk for coronary heart disease
Lance A Bare, Alanna C Morrison, Charles M Rowland, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 252) with videos related to
Sort By:
Page
of 26
Journal of the American College of Cardiology
|
January 5, 2008
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials
Stuart J Pocock, Alexandra J Lansky, Roxana Mehran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
July 8, 2021
Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement
Toshiaki Isogai, Anas M Saad, Keerat Rai Ahuja, et al.
JACC. Cardiovascular Interventions
|
April 23, 2011
Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators
Stephen G Ellis, Mehdi H Shishehbor, Samir R Kapadia, et al.
Coronary Artery Disease
|
June 10, 2014
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies
Nobuaki Kobayashi, Akiko Maehara, Dominic Allocco, et al.
Human Genetics
|
November 4, 2009
The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies
Sonny Dandona, Li Chen, Meng Fan, et al.
The American Journal of Cardiology
|
January 15, 2022
A Validated Model to Identify Patients With Low Likelihood of High-Risk Coronary Artery Disease Anatomy
Amr F Barakat, Ram Amuthan, Essa Hariri, et al.
JACC. Cardiovascular Interventions
|
February 5, 2010
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials
Hiroshi Doi, Akiko Maehara, Gary S Mintz, et al.
Journal of the American College of Cardiology
|
October 17, 2009
Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards
David E Kandzari, Antonio Colombo, Seung-Jung Park, et al.
Journal of the American College of Cardiology
|
June 6, 2006
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials
Jeffrey W Moses, Gregg W Stone, Eugenia Nikolsky, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 13, 2007
Five common gene variants identify elevated genetic risk for coronary heart disease
Lance A Bare, Alanna C Morrison, Charles M Rowland, et al.
Page
of 26